Understanding liver cancer risk in Hispanics with cirrhosis
Official title: Multilevel factors associated with heterogeneity in risk of liver cancer within Hispanics with cirrhosis
Funded at Baylor College of Medicine · NIH-11080090 · Data updated 2026-11-12
This study is looking at what might increase or decrease the chances of getting liver cancer in Hispanic people who have cirrhosis, and it aims to find ways to help with early detection and prevention.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | July 1, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $98,355 |
| NIH project number | 3P01CA263025-03S1 |
| Project ID | NIH-11080090 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Hispanic individuals diagnosed with cirrhosis, particularly those affected by metabolic liver disease.
✕Less likely to help
Patients without cirrhosis or those from non-Hispanic backgrounds may not benefit from this research.
What this research studies
This research investigates the various factors that contribute to the risk of liver cancer, specifically focusing on Hispanic individuals with cirrhosis. By analyzing a large cohort of patients, the study aims to identify both risk and protective factors related to metabolic liver disease. The approach includes measuring metabolic traits and biomarkers, as well as exploring strategies for prevention and early diagnosis of liver cancer. Patients may be involved in assessments that could lead to improved surveillance and treatment options.
Why it matters
Potential benefit: If successful, this research could lead to better prevention and treatment strategies for liver cancer in Hispanic populations.
How similar studies have gone: Previous research has shown promising results in understanding liver cancer risk factors in diverse populations, making this approach both relevant and potentially impactful.
Where this research is happening
-
Baylor College of Medicine
Houston, United States Active
Researchers
- Principal investigator: El-Serag, Hashem B — Baylor College of Medicine
- Study coordinator: El-Serag, Hashem B
Related research
Other NIH-funded projects on the same topics.
-
Early detection of liver cancer risk in people with cirrhosis and MASLD
A small research grant to explore better ways to find liver cancer early among people with cirrhosis and MASLD so they can get timely care.
-
AI-powered liver cancer screening using ultrasound blood flow patterns
A new AI-based method analyzes liver blood flow signals to help detect liver cancer early in people with liver disease, especially in settings with limited resources.
-
Aging and liver cancer: new ways to prevent and fight hepatocellular carcinoma
This research explores how aging promotes liver cancer and tests new preventive approaches that could help people at higher risk due to age.
-
Statin therapy for people with compensated cirrhosis
A big, long-term study at a major university is looking at whether statins can help people with compensated cirrhosis live longer and feel better.
-
Liver Cirrhosis Network: Centers for Clinical Research
A multicenter study in people with cirrhosis from different causes (including HIV, NASH, and alcohol-related liver disease) to collect data and samples and test new ways to predict and monitor disease progression.
-
Outcomes in cirrhosis from different causes and the role of HIV and simvastatin
This study looks at how cirrhosis from alcohol, HIV, and other causes affects patients and whether simvastatin can influence outcomes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.